Research Articles | Page 14 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Treatment options for lower-risk myelodysplastic syndromes. Where are we now? Jan 2021 Therapeutic Advances in Hematology myelodysplastic syndromes (MDS)
Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management" Jan 2021 American Journal of Hematology myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series Jan 2021 Annals of Hematology aplastic anemia
Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS) Jan 2021 Cancer Causes & Control : CCC myelodysplastic syndromes (MDS)
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study Jan 2021 Journal of clinical oncology: official journal of the American Society Clinical Oncology myelodysplastic syndromes (MDS)
Allogeneic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes and Prevention of Relapse Jan 2021 Clinical Lymphoma , Myeloma & Leukemia myelodysplastic syndromes (MDS)
The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia Jan 2021 Seminars in Hematology acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Current and emerging strategies for management of myelodysplastic syndromes Dec 2020 Blood reviews myelodysplastic syndromes (MDS)
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium Dec 2020 Cancer Medicine myelodysplastic syndromes (MDS)
Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology Dec 2020 Journal of Managed care and specialty pharmacy paroxysmal nocturnal hemoglobinuria (PNH)
Share with addtoany.com.